Ergoteles’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Ergoteles’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-93,400	Closed	-$1.75M	–	1624
2023 Q1	$1.75M	Buy	+93,400	New	+$1.53M	0.07%	315
2022 Q1	–	Sell	-13,040	Closed	-$381K	–	1702
2021 Q4	$381K	Sell	13,040 -5,660	-30%	-$162K	0.01%	755
2021 Q3	$403K	Buy	+18,700	New	+$451K	0.01%	677
2021 Q2	–	Sell	-10,673	Closed	-$195K	–	1727
2021 Q1	$195K	Buy	+10,673	New	+$177K	0.01%	678

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ergoteles's CDMO Position: Q2 2023 in Review

Ergoteles sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2023, closing a stake of 93,400 shares — an estimated $1.75M sold.

Ergoteles first reported a position in CDMO in Q1 2021 and held it in 4 quarters. The position peaked at $1.75M in Q1 2023. 169 funds tracked by Wall St. Rank hold CDMO as of Q2 2023.

Ergoteles reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 93,400 Avid Bioservices, Inc. Common Stock shares in Q2 2023, an estimated $1.75M.
Ergoteles first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Ergoteles's Avid Bioservices, Inc. Common Stock position peaked at $1.75M in Q1 2023.
169 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.